Search Results - "Waugh, Nichola"

Effectiveness of septoplasty compared to medical management in adults with obstruction associated with a deviated nasal septum: the NAIROS RCT by Carrie, Sean, Fouweather, Tony, Homer, Tara, O'Hara, James, Rousseau, Nikki, Rooshenas, Leila, Bray, Alison, Stocken, Deborah D, Ternent, Laura, Rennie, Katherine, Clark, Emma, Waugh, Nichola, Steel, Alison J, Dooley, Jemima, Drinnan, Michael, Hamilton, David, Lloyd, Kelly, Oluboyede, Yemi, Wilson, Caroline, Gardiner, Quentin, Kara, Naveed, Khwaja, Sadie, Leong, Samuel Chee, Maini, Sangeeta, Morrison, Jillian, Nix, Paul, Wilson, Janet A, Teare, M Dawn

“…The indications for septoplasty are practice-based, rather than evidence-based. In addition, internationally accepted guidelines for the management of nasal…”
Get full text

Using the AR-V7 biomarker to determine treatment in metastatic castrate resistant prostate cancer, a feasibility randomised control trial, conclusions from the VARIANT trial [version 2; peer review: 2 approved] by Rebecca Maier, Aislinn Cooper, Robert Chandler, John Marshall, Simon Crabb, Amit Bahl, Ian Pedley, Suneil Jain, John Staffurth, Rob Jones, Rakesh Heer, Paul Gravestock, Miranda Morton, Emma Clark, Holly Fisher, Shirya Sharma, Ruth Wood, Jenn Walker, Nichola Waugh, Helen Hancock

“…Background: Prostate cancer is the most commonly diagnosed malignancy in the UK. Castrate resistant prostate cancer (CRPC) can be difficult to manage with…”
Get full text

Using the AR-V7 biomarker to determine treatment in metastatic castrate resistant prostate cancer, a feasibility randomised control trial, conclusions from the VARIANT trial by Gravestock, Paul, Clark, Emma, Morton, Miranda, Sharma, Shirya, Fisher, Holly, Walker, Jenn, Wood, Ruth, Hancock, Helen, Waugh, Nichola, Cooper, Aislinn, Maier, Rebecca, Marshall, John, Chandler, Robert, Bahl, Amit, Crabb, Simon, Jain, Suneil, Pedley, Ian, Jones, Rob, Staffurth, John, Heer, Rakesh

“…Prostate cancer is the most commonly diagnosed malignancy in the UK. Castrate resistant prostate cancer (CRPC) can be difficult to manage with response to next…”
Get full text

Using the AR-V7 biomarker to determine treatment in metastatic castrate resistant prostate cancer, a feasibility randomised control trial, conclusions from the VARIANT trial by Gravestock, Paul, Clark, Emma, Morton, Miranda, Sharma, Shirya, Fisher, Holly, Walker, Jenn, Wood, Ruth, Hancock, Helen, Waugh, Nichola, Cooper, Aislinn, Maier, Rebecca, Marshall, John, Chandler, Robert, Bahl, Amit, Crabb, Simon, Jain, Suneil, Pedley, Ian, Jones, Rob, Staffurth, John, Heer, Rakesh

“…Background : Prostate cancer is the most commonly diagnosed malignancy in the UK. Castrate resistant prostate cancer (CRPC) can be difficult to manage with…”
Get full text